Core Molding Technologies vs Myers Industries
CMT and MYE side by side, both in miscellaneous plastics products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CMT and MYE compare
Myers Industries is the larger company, worth 5.4 times as much as Core Molding Technologies ($1.1B against $196M).
On earnings, Core Molding Technologies is cheaper: it trades at 27.4× trailing earnings, against 36.9× for Myers Industries.
Myers Industries grew revenue faster over the last twelve months (24.8% versus 9.4% for Core Molding Technologies).
Myers Industries keeps more of each dollar of sales as profit, with a net margin of 3.3% compared with 2.4% at Core Molding Technologies.
Myers Industries pays a dividend yielding 1.9%; Core Molding Technologies does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CMT | MYE |
|---|---|---|
| Size and price | ||
| Market cap | $196M | $1.1B |
| Share price | $22.17 | $28.07 |
| Change, 1 year | 16.0% | 56.9% |
| Change, 5 years | 135% | 37.0% |
| Beta (5Y) | 0.62 | 0.77 |
| Employees | 1,239 | 2,200 |
| StockData Score | ||
| Total score | 12 | 12 |
| Valuation score | 3 (better) | 1 |
| Growth score | 2 | 3 (better) |
| Performance score | 1 | 2 (better) |
| Health score | 6 (better) | 2 |
| Dividend score | 0 | 4 (better) |
| Valuation | ||
| P/E | 27.4× (better) | 36.9× |
| P/S | 0.7× (better) | 1.2× |
| P/B | 1.2× (better) | 3.5× |
| EV/EBITDA | 9.6× (better) | 11.9× |
| P/FCF | – | 13.0× |
| FCF yield | −9.8% | 7.7% (better) |
| Fair value | $22.39 | $23.99 |
| Margin of safety | 1.00% (better) | −17.0% |
| Growth | ||
| Revenue growth (TTM) | 9.4% | 24.8% (better) |
| Revenue growth, 5Y average | 4.3% | 10.1% (better) |
| Net income growth (TTM) | −13.5% | 2.8% (better) |
| EPS growth (TTM) | −13.8% | 2.7% (better) |
| EPS growth, 5Y average | 5.7% (better) | −1.8% |
| Profitability | ||
| Gross margin | 17.3% | 33.9% (better) |
| Operating margin | 2.9% | 10.7% (better) |
| Net margin | 2.4% | 3.3% (better) |
| FCF margin | −6.7% | 9.5% (better) |
| Return on equity | 4.4% | 9.7% (better) |
| Return on invested capital | 4.7% | 12.5% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.96 (better) |
| Net debt / EBITDA | −0.27 | 2.19 (better) |
| Interest coverage | 49.1× | – |
| Current ratio | 1.86 | 1.89 (better) |
| Altman Z-score | 4.19 (better) | 2.89 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 1.9% |
| Payout ratio | – | 71.4% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 0.00% |
| Buyback yield | 1.6% (better) | −0.07% |
| Shareholder yield | 1.6% | 1.9% (better) |
| Ownership | ||
| Held by institutions | 72.7% | 97.2% |
| Held by insiders | 14.2% | 10.3% |
| Insider net buying, 12 months | −$328K | $0 (better) |
| Short interest, % of float | 2.6% | 4.7% |
Go deeper
- CMT stock overview
- CMT income statement
- CMT valuation and score
- MYE stock overview
- MYE income statement
- MYE valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.